Trump receives experimental antibody treatment for Covid-19 diagnosis

President Donald Trump has received an experimental drug following his diagnosis of Covid-19, the White House said Friday.

The drug cocktail is a combination of two so-called monoclonal antibodies. The treatment is meant to provide the body's immune system with a temporary but immediate boost to fight off the coronavirus.

Monoclonal antibodies are made in a lab to mimic the body's natural antibodies. Antibodies act by recognizing specific germs — in this case, SARS-CoV-2, the virus that causes Covid-19 — and harnessing the immune system to fight them off.

Full coverage of the coronavirus outbreak

The therapy, though still unproven, is considered by experts to be one of the most promising treatment options for the illness.

Regeneron confirmed it provided its drug to the president under what is called "compassionate use," through which the Food and Drug Administration allows access to experimental drugs outside of clinical trials for patients with life-threatening conditions or serious diseases.

Download the NBC News app for full coverage of the coronavirus outbreak

The treatment is being studied in clinical trials as a potential treatment for and possible prevention of illness in people who have been exposed. The drug company said Tuesday that early evidence from the trials suggest that the treatment appears to be beneficial in patients with mild to moderate illness.

For Subscribers

FOR SUBSCRIBERSWhat happened inside the room where officials tried to execute Christa Pike by lethal injection

FOR SUBSCRIBERS‘We’re going to beat you to death with audits’: Brad Raffensperger gears up to oversee his final election in Georgia

FOR SUBSCRIBERSHow we reported the saga of the CIA officer and his gold-bar stash

FOR SUBSCRIBERSDiddy is punished following NBC News report on his VIP life in prison and contraband cellphone use

FOR SUBSCRIBERS‘Too young to vote, old enough to be tear gassed’: French protesters’ anger swells

FOR SUBSCRIBERSDOJ gets aggressive in suing states that challenge Trump’s immigration policies

FOR SUBSCRIBERSJustice Department seeks criminal charge for former Trump aide Cassidy Hutchinson

FOR SUBSCRIBERS‘I just want to hold him’: USS Lincoln sailor to meet his 10-month-old son as ship docks

FOR SUBSCRIBERSSenate candidates run on raising Social Security taxes for higher incomes to prevent benefit cuts

FOR SUBSCRIBERSRussian operation that used ChatGPT tricked schools, a politician and media, OpenAI says

FOR SUBSCRIBERSTrump administration’s deal with Nevada fuels data center fight in governor’s race

FOR SUBSCRIBERSLatino voters reject Trump’s immigration policies — and detail the personal impact

FOR SUBSCRIBERSAs Democrats eye big midterm gains, the Wisconsin governor’s race remains a nail-biter

FOR SUBSCRIBERSU.S. military prepares new Iran war options ahead of midterm elections

FOR SUBSCRIBERSCIA probe into intel leak led to discovery of gold bars at agent’s home, sources say

Slide 1 of 1

For Subscribers

FOR SUBSCRIBERSWhat happened inside the room where officials tried to execute Christa Pike by lethal injection

FOR SUBSCRIBERS‘We’re going to beat you to death with audits’: Brad Raffensperger gears up to oversee his final election in Georgia

FOR SUBSCRIBERSHow we reported the saga of the CIA officer and his gold-bar stash

FOR SUBSCRIBERSDiddy is punished following NBC News report on his VIP life in prison and contraband cellphone use

FOR SUBSCRIBERS‘Too young to vote, old enough to be tear gassed’: French protesters’ anger swells

FOR SUBSCRIBERSDOJ gets aggressive in suing states that challenge Trump’s immigration policies

FOR SUBSCRIBERSJustice Department seeks criminal charge for former Trump aide Cassidy Hutchinson

FOR SUBSCRIBERS‘I just want to hold him’: USS Lincoln sailor to meet his 10-month-old son as ship docks

FOR SUBSCRIBERSSenate candidates run on raising Social Security taxes for higher incomes to prevent benefit cuts

FOR SUBSCRIBERSRussian operation that used ChatGPT tricked schools, a politician and media, OpenAI says

FOR SUBSCRIBERSTrump administration’s deal with Nevada fuels data center fight in governor’s race

FOR SUBSCRIBERSLatino voters reject Trump’s immigration policies — and detail the personal impact

FOR SUBSCRIBERSAs Democrats eye big midterm gains, the Wisconsin governor’s race remains a nail-biter

FOR SUBSCRIBERSU.S. military prepares new Iran war options ahead of midterm elections

FOR SUBSCRIBERSCIA probe into intel leak led to discovery of gold bars at agent’s home, sources say

Slide 1 of 1

"It decreased viral load and made symptoms resolve faster," said Dr. Todd Rice, an associate professor of medicine at Vanderbilt University Medical Center in Nashville, Tennessee. Rice is not involved with Regeneron's clinical trials.

Trump is said to have mild symptoms, including fatigue and a low-grade fever. As a precautionary measure, the president has been taken to Walter Reed National Military Medical Center.

The letter from the president's physician also said Trump has been taking zinc, vitamin D, the heartburn drug famotidine, a daily aspirin and a sleep aid called melatonin. All of those are sold over the counter. There is no solid evidence that any might help treat Covid-19.

Follow NBC HEALTH on Twitter & Facebook.

CLARIFICATION (Oct. 4, 2020, 10:34 a.m. ET): An earlier version of this article quoted a White House physician as saying that the president on Friday received “a single 8-gram dose of Regeneron’s polyclonal antibody cocktail.” The drugmaker Regeneron later told NBC News that Trump received a combination of two monoclonal antibodies, not one. The article has been updated.